We are live on ! Find out more
IMC Chicago

IMC Chicago Portfolio holdings

AUM $278B
1-Year Est. Return 44.93%
 

IMC-Chicago, a key arm of IMC Trading founded in 1989 by Rob Defares and René Schelvis in Amsterdam, is a proprietary trading firm and market maker headquartered in Chicago since opening its first overseas office there in 2000. Employing over 650 of IMC’s 1,600+ global workforce, it operates at the heart of North America’s financial hub, trading equities, options, futures, and other derivatives on major exchanges like the Chicago Mercantile Exchange (CME) and Chicago Board Options Exchange (CBOE). Known for its technology-driven approach, IMC-Chicago leverages advanced algorithms and low-latency systems to provide liquidity across more than 100 global venues, evolving from a trading outfit with strong tech to a tech company that trades. Under CEO Rob Defares, the firm emphasizes innovation, quantitative strategies, and a collaborative culture, making it a powerhouse in the U.S. derivatives market.

This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+44.93%
3 Year Est. Return
+175.12%
5 Year Est. Return
+169.81%
10 Year Est. Return
AUM
$81.5B
AUM Growth
+$12.6B
Cap. Flow
+$4.98B
Cap. Flow %
6.1%
Top 10 Hldgs %
52.52%
Holding
1,215
New
194
Increased
462
Reduced
430
Closed
124

Sector Composition

Rank Sector Weight
1 Industrials 0.17%
2 Technology 0.12%
3 Communication Services 0.11%
4 Consumer Discretionary 0.1%
5 Healthcare 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIVE icon
651
CALL
Five Below
FIVE
$11.2B
$3.58M ﹤0.01%
18,500
+500
+3% +$95.5K
IQ icon
652
PUT
iQIYI
IQ
$1.18B
$3.56M ﹤0.01%
228,800
-235,500
-51% -$3.5M
VLO icon
653
CALL
Valero Energy
VLO
$89.8B
$3.54M ﹤0.01%
45,400
+25,900
+133% +$2.01M
TEVA icon
654
PUT
Teva Pharmaceuticals
TEVA
$35.9B
$3.53M ﹤0.01%
356,400
+54,400
+18% +$576K
CIEN icon
655
CALL
Ciena
CIEN
$55.3B
$3.51M ﹤0.01%
61,700
-25,800
-29% -$1.42M
VALE icon
656
CALL
Vale
VALE
$62.9B
$3.49M ﹤0.01%
153,200
+9,800
+7% +$205K
FRLG
657
DELISTED
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
$3.49M ﹤0.01%
+11,952
New +$3.23M
MNDT
658
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.48M ﹤0.01%
171,900
-23,600
-12% -$484K
ILCV icon
659
CALL
iShares Morningstar Value ETF
ILCV
$1.3B
$3.47M ﹤0.01%
39,400
-257,400
-87% -$16.5M
SCHQ
660
Schwab Long-Term US Treasury ETF
SCHQ
$781M
$3.47M ﹤0.01%
69,168
+40,223
+139% +$1.95M
DFS
661
CALL
DELISTED
Discover Financial Services
DFS
$3.47M ﹤0.01%
29,300
-1,500
-5% -$170K
JBLU icon
662
PUT
JetBlue
JBLU
$1.96B
$3.45M ﹤0.01%
205,400
-3,600
-2% -$69.7K
JBLU icon
663
CALL
JetBlue
JBLU
$1.96B
$3.4M ﹤0.01%
202,900
+9,600
+5% +$186K
VIPS icon
664
Vipshop
VIPS
$6.84B
$3.4M ﹤0.01%
169,475
+107,001
+171% +$2.69M
UCO icon
665
ProShares Ultra Bloomberg Crude Oil
UCO
$443M
$3.38M ﹤0.01%
172,576
+75,844
+78% +$1.24M
KR icon
666
PUT
Kroger
KR
$34.8B
$3.36M ﹤0.01%
87,800
+39,100
+80% +$1.47M
UPWK icon
667
CALL
Upwork
UPWK
$1.09B
$3.36M ﹤0.01%
57,700
-6,000
-9% -$282K
TEVA icon
668
CALL
Teva Pharmaceuticals
TEVA
$35.9B
$3.33M ﹤0.01%
336,700
-26,000
-7% -$275K
BDX icon
669
PUT
Becton Dickinson
BDX
$43.1B
$3.33M ﹤0.01%
+14,043
New +$3.37M
INO icon
670
CALL
Inovio Pharmaceuticals
INO
$79.8M
$3.32M ﹤0.01%
29,808
-12,109
-29% -$1.16M
URTY icon
671
ProShares UltraPro Russell2000
URTY
$323M
$3.31M ﹤0.01%
28,432
-48,650
-63% -$5.4M
SQQQ icon
672
ProShares UltraPro Short QQQ
SQQQ
$2.21B
$3.27M ﹤0.01%
2,858
-3,022
-51% -$4.15M
CGC
673
CALL
Canopy Growth
CGC
$375M
$3.26M ﹤0.01%
13,470
-7,390
-35% -$1.89M
SRPT icon
674
CALL
Sarepta Therapeutics
SRPT
$1.66B
$3.2M ﹤0.01%
41,200
-58,700
-59% -$4.45M
BHC icon
675
PUT
Bausch Health
BHC
$1.65B
$3.2M ﹤0.01%
109,200
-16,300
-13% -$494K

Similar funds

IMC Chicago's Q2 2021 Portfolio in Review

As of Q2 2021, IMC Chicago held 1,215 positions worth $81.5B, up 18% from $68.9B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

IMC Chicago deployed $4.98B of net new capital in Q2 2021, opening 194 new positions and adding to 462 existing holdings. Its largest new stake was SPDR Gold Trust: 379,729 shares worth $62.9M.

By sector, the portfolio is most concentrated in Industrials at 0.17% of assets, up from 0.1% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Gold Trust, an estimated $63.7M trimmed.

  • IMC Chicago's largest Q2 2021 buy was SPDR Gold Trust: 379,729 shares worth $62.9M.
  • IMC Chicago added most to Invesco QQQ Trust in Q2 2021, an estimated $188M increase.
  • IMC Chicago's biggest Q2 2021 reduction was iShares Gold Trust, cutting an estimated $63.7M.
  • IMC Chicago fully exited Alphabet (Google) Class A in Q2 2021, selling an estimated $64.9M.
  • IMC Chicago's ten largest holdings make up 53% of its $81.5B portfolio in Q2 2021.
  • IMC Chicago opened 194 new positions and closed 124 in Q2 2021.
  • IMC Chicago's portfolio value rose 18% quarter-over-quarter to $81.5B.

Based on IMC Chicago's 13F filing for Q2 2021, filed 6 Aug 2021.